Perfil
Olivier Meyer is the founder of Carlina Technologies SAS, which was founded in 2010.
He held the title of President & Chief Executive Officer at Carlina Technologies SAS.
Dr. Meyer's former jobs include President & Chief Executive Officer at Bioxel Pharma, Inc., Assistant Director at AstraZeneca SAS, and Head-Laboratory at Transgene SA. Dr. Meyer received a doctorate degree from Université de Paris XI Paris Sud in 1995.
Antiguos cargos conocidos de Olivier Meyer.
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | - |
Carlina Technologies SAS
 Carlina Technologies SAS BiotechnologyHealth Technology Carlina Technologies SAS operates as a biopharmaceutical company. It specializes in the development of nanomedicines utilizing non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs. The firm also provides formulation development and product development, process manufacturing, preclinical batch production, scale-up and technology transfer, analytical method development, and stability studies services. It serves the pharmaceutical, biotechnology, and veterinary industries. The company was founded by Olivier Meyer and Jean-Pierre Benoît in 2010 and is headquartered in Angers, France. | Director Ejecutivo | - |
| TRANSGENE | Corporate Officer/Principal | - |
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Director Ejecutivo | - |
Formación de Olivier Meyer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Empresas privadas | 4 |
|---|---|
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Health Technology |
Carlina Technologies SAS
Carlina Technologies SAS BiotechnologyHealth Technology Carlina Technologies SAS operates as a biopharmaceutical company. It specializes in the development of nanomedicines utilizing non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs. The firm also provides formulation development and product development, process manufacturing, preclinical batch production, scale-up and technology transfer, analytical method development, and stability studies services. It serves the pharmaceutical, biotechnology, and veterinary industries. The company was founded by Olivier Meyer and Jean-Pierre Benoît in 2010 and is headquartered in Angers, France. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
- Bolsa de valores
- Insiders
- Olivier Meyer
